OnPoint Surgical Receives Award for Newly Granted U.S. Patent regarding Augmented Reality Guidance for Spinal Surgery

OnPoint Surgical is revolutionizing spinal surgery, including deformity correcting, minimally invasive and endoscopic spine procedures. Their Augmented Reality (AR) platform technology superimposes virtual surgical guides and virtual spinal implants onto the patient’s physical spine, directly in the surgeon’s visual field, using a novel see-through optical head-mounted display.

The technology offers many clinical and intra-operative benefits paired with impressive accuracy, procedural efficiency, and time savings. The OnPoint AR technology is applicable to manual surgery, and is also an enabler for the next generation of robotic systems, using optics instead of, or in conjunction with, haptics.

The Invented Here! The program celebrates New England innovators, their inventions, and the stories behind their innovations. With this program, the Boston Patent Law Association (BPLA) is transforming the nation’s relationship with science and technology and providing educational opportunities that inform the public of these fascinating innovations. The 2021 Invented Here! The ceremony is particularly notable given the participation of representatives of the United States Patent Office.

“We are thrilled to be recognized for the third year in a row for our innovations in the area of Augmented Reality and surgical guidance,” said Philipp Lang, MD, Founder, and CEO of the OnPoint Companies.  “Spinal procedures are technically complex requiring high spatial accuracy. Accurate execution of the surgery is paramount to achieving excellent outcomes for spinal patients. OnPoint Augmented Reality technology offers greatly improved hand-eye coordination for surgeons by directly displaying virtual surgical guides onto the patient’s spine to improve accuracy and helps to quickly return patients to normal, everyday activities. The ability to display virtual spinal implants directly on the physical spine using augmented reality display prior to any irreversible surgical steps advances non-robotic, manual, and robot-guided surgery to an entirely new performance level, opening up the opportunity of improved clinical outcomes, less pain, and faster recovery for millions of spinal patients.”

OnPoint Medical, OnPoint Surgical, OnPoint Knee, OnPoint Hip and OnPoint Sports are privately-held medical device companies pioneering Augmented Reality (AR) guidance for several procedures, including spinal surgery, knee replacement, hip replacement, arthroscopic, and robotic procedures. The companies have a Scientific Advisory Board from world-renowned institutions including Harvard Medical School, Stanford University, Weill Cornell Medical College, and other prominent institutions across the United States.

OnPoint technology is broadly applicable to all spinal, neurosurgical, orthopedic, arthroscopic, and other surgical procedures. OnPoint is expanding into multiple new applications and indications.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”